GTCbio announces its 4th International Stem Cell Research and Therapeutics Conference

Released on: January 23, 2008, 3:51 pm

Press Release Author: GTCbio

Industry: Pharmaceuticals

Press Release Summary: GTCbio announces the 4th International Stem Cell Research &
Therapeutics on April 17-18, 2008 in Boston, MA - featuring a keynote presentation
from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of
transgenic science, and a leader in the field of therapeutic cloning, also called
nuclear transfer.

Press Release Body: GTCbio is announcing the 4th international Stem Cell Research &
Therapeutics Conference taking place on April 17-18, 2008 in Boston, MA. The
conference covers the latest developments in all aspects of stem cell research from
leading stem cell companies, universities and government organizations.

The goal of the Conference is to provide an overview of the state of art in the
field of stem cells, bringing together a mix of academic, industry (Pharma and
Biotech) and public sector experts in an intimate setting that favors the showcase
of data, the exchange of ideas and networking.

Attendees learn from top leaders and experts on adult stem cells, embryonic stem
cells, differentiation, epigenomics & reprogramming, regenerative medicine &
therapeutics, stem cell imaging, cancer stem cells, stem cell applications in drug
discovery, and stem cells regulatory aspects & funding opportunities.

The keynote speaker, Dr. Rudolf Jaenisch who is a founding Member of the Whitehead
Institute and a pioneer of transgenic science will open the conference with a talk
on his latest research. Dr. Jaenisch is a leader in the field of therapeutic
cloning, also called nuclear transfer. The conference also features presentations
from leading organizations such as Beckman Research Institute, FDA, Genzyme, Merck,
MIT, Pfizer, Sangamo BioSciences, Sanofi Aventis, University of Van Amsterdam, and
many more. The full agenda is available online at www.gtcbio.com.


ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com


Web Site: http://www.gtcbio.com

Contact Details: GTCbio
434 W Foothill Blvd.
Monrovia, CA 91016

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •